Skip to main content

Table 8 CTSK expression concerning the different TNM clinical stages using One-way ANOVA Post hoc test for multiple comparisons

From: Clinicopathological correlation of Cathepsin K expression in salivary gland carcinomas; relation to patients` outcome

(I) TNM clinical stage

(J) TNM clinical stage

Mean Difference (I-J)

Std. Error

Sig

95% Confidence Interval

Lower Bound

Upper Bound

stage I

stage II

-1.071a

.516

.044

-2.11

-.03

stage III

-1.571a

.435

.001

-2.45

-.69

stage IV

-2.256a

.410

.000

-3.08

-1.43

stage II

stage I

1.071a

.516

.044

.03

2.11

stage III

-.500

.458

.281

-1.43

.43

stage IV

-1.184a

.435

.009

-2.06

-.31

stage III

stage I

1.571a

.435

.001

.69

2.45

stage II

.500

.458

.281

-.43

1.43

stage IV

-.684a

.334

.047

-1.36

-.01

stage IV

stage I

2.256a

.410

.000

1.43

3.08

stage II

1.184a

.435

.009

.31

2.06

stage III

.684a

.334

.047

.01

1.36

  1. a The mean difference is significant at the 0.05 level